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Mid-ventricular obstructive hypertrophic cardiomyopathy
(MVOHCM) is a rare type of cardiomyopathy, associated with
apical aneurysm formation in some cases. We report a patient
presenting with ventricular fibrillation, an ECG with an above
normal ST segment, and elevated levels of cardiac enzymes
but normal coronary arteries. Left ventriculography revealed
a left ventricular obstruction without apical aneurysm. There
was a significant pressure gradient between the apical and
basal sites of the left ventricle. Cine magnetic resonance
imaging (MRI), performed on the 10th hospital day, showed
asymmetric septal hypertrophy, mid-ventricular obstruction,
and an apical aneurysm with a thrombus. The first evaluation
by contrast-enhanced imaging showed a subendocardial
perfusion defect and delayed enhancement. It was speculated
that the intraventricular pressure gradient, due to mid-
ventricular obstruction, triggered myocardial infarction, which
subsequently resulted in apical aneurysm formation.
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INTRODUCTION
Mid-ventricular obstructive hypertrophic cardi-
omyopathy (MVOHCM) is a rare form of cardio-
myopathy, characterized by the presence of a
pressure gradient between the left ventricular
basal and apical chambers, as well as by asy-
mmetric left ventricular hypertrophy. MVOHCM
is frequently associated with an apical aneur-
ysm,
1-7 but the mechanism of aneurysm formation
remains unknown. We describe a patient with
MVOHCM in whom the apical aneurysm deve-
loped rapidly after an episode of acute myocardial
ischemia.
CASE REPORT
A 58-year-old man presented with ventricular
fibrillation. There was no family history of
cardiomyopathy or sudden death. After successful
defibrillation, his blood pressure was 106/60
mmHg, and his pulse rate was 80 beats/min. A
12-lead ECG showed ST-segment elevations in
leads V3-V6 but no Q waves. Chest X-ray showed
no cardiomegaly or pulmonary congestion. Labo-
ratory examination revealed a mild increase in
creatine kinase-MB (38 mIU/mL) and troponin T
(0.3 ng/mL) levels. With provisional diagnosis of
acute myocardial infarction, coronary angiogra-
phy and left ventriculography were performed.
Coronary angiography yielded normal results
(Fig. 1A), but the left ventriculogram showed
severe left ventricular obstruction during systole
with no aneurysmal bulging in the apical segment
(Fig. 1B). There was a significant pressure
gradient (45 mmHg) between the basal and apical
sites of the left ventricle at rest (Fig. 2). Using
continuous wave Doppler echocardiography, the
pressure gradient was measured as 60 mmHg.
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The patient had been diagnosed as having
MVOHCM, and medical treatment with a beta
blocker and amiodarone was started. ECG-gated,
magnetic resonance imaging (MRI) was performed
on the 10th hospital day, using an Intera Achieva
(1.5 T, Philips Medical Systems, Best, Netherlands).
Cine MRI showed mid-ventricular obstruction and
an apical aneurysm with a large thrombus on long-
axis (Fig. 3A) and 4-chamber (Fig. 3B) images.
Initial gadolinium-diethylenetriomine pentaacetic
acid-enhanced imaging showed reduced subendo-
myocardial perfusion in the mid-ventricular por-
tion of the left ventricle (Fig 3C). Fifteen minutes
later, delayed enhancement of the subendomyo-
cardium was noted (Fig. 3D). Because medical
treatment with a beta blocker (carvedilol) did not
Fig. 1. (A) Coronary aniogram showing normal left (left
panel) and right (right panel) coronary arteries. (B) Left
ventriculogram in the 30° right anterior oblique pro-
jection, showing a small left ventricular cavity during
diastole (left panel) and complete obstruction of the
apical site during systole (right panel).
Fig. 2. Left ventricular pressure in the apex (upper
panel) and in the base (lower panel), showing a
pressure gradient of 45 mmHg.
Fig. 3. ECG-gated, cine magnetic resonance
imaging of the long axis (A) and 4-chamber
view (B), showing mid-ventricular obstruc-
tion during systole (large arrows) (lower
panels), an apical aneurysm (small arrows),
and a thrombus (Th, upper panels) during
diastole. Contrast-enhanced first-pass myo-
cardial perfusion (C) and delayed enhancement
(D) images, showing a subendomyocardial
perfusion defect (arrows) and delayed
enhancement (arrows), respectively.Hypertrophic Cardiomyopathy with Apical Aneurysm
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reduce the intraventricular pressure gradient de-
termined by continuous wave Doppler echocar-
diography, the patient underwent surgery in
which left ventricular aneurysmectomy and
removal of the thrombus were performed. The
patient received a beta-blocker postoperatively,
and the 8-week follow-up period was uneventful.
DISCUSSION
MVOHCM is a rare form of hypertrophic
cardiomyopathy, characterized by the presence of
a pressure gradient between the apical and basal
chambers of the left ventricle. It is frequently
associated with an apical aneurysm without
significant atherosclerotic coronary artery disease.
1-7 The mechanisms responsible for apical aneur-
ysm formation are not well understood. Major
causes of aneurysm formation that have been
proposed are increased afterload and high apical
pressure, resulting from mid-ventricular obstruc-
tion, which lead to compression of the intramyo-
cardial coronary arteries and/or greater oxygen
demand due to increased myocardial thickness
and decreased oxygen supply due to the de-
creased capillary network.
7 In addition, the apex
is subject to greater and sustained systolic stress
due to the high pressure gradient. In two cases,
Maron et al. discovered extremely high pressure
in the apex (260 mmHg and 225 mmHg)
8. How-
ever, in the present case, the peak systolic pres-
sure in the apex was 135 mmHg, which might not
be sufficient to cause aneurysmal bulging.
Furthermore, apical hypertrophic cardiomyopathy
may show a myocardial perfusion defect in the
apex on stress images even in the absence of
epicardial coronary artery obstruction, suggesting
decreased coronary flow reserve in the hyper-
trophic apical segment.
9 One limitation of our
report is that we do not have evidence of apical
hypertrophic cardiomyopathy in our patient prior
to the acute ischemic event. The process of
aneurysm formation has been believed to occur
over a long period of time due to predisposing
ischemic episodes resulting from a chronic in-
crease of systolic wall stress.
7,10,11 However, the
present case involved rapid aneurysm develop-
ment within 10 days after the acute ischemic
episode. A left ventriculogram showed no an-
eurysm, and the increase in cardiac enzyme levels
was mild in the acute phase, whereas MRI
performed after 10 days revealed extensive myo-
cardial necrosis at the site of the apical aneurysm.
Thus, it was hypothesized that the initially small
infarction arose in the apex as a result of com-
pression of intramyocardial coronary arteries
and/or oxygen supply-demand imbalance and
expanded rapidly because of the further increase
in systolic wall stress due to the sustained pre-
ssure gradient.
Management of MVOHCM is obscure because
it may result in life-threatening ventricular arrhy-
thmias
4 and sudden death.
5 Generally, beta
blockers are the first choice of treatment for
patients with subaortic obstructive hypertrophic
cardiomyopathy,
12 but the optimal treatment for
MVOHCM has not yet been established. Dual-
chamber pacing
13,14 and percutaneous myocardial
ablation
6,15 have been proposed as non-surgical
treatments, but their long-term prognosis and
procedural safety await further observation with
a large patient population.
In conclusion, our case demonstrated that apical
aneurysm may develop rapidly after an episode of
acute myocardial ischemia in patients with
MVOHCM. Acute increase in the intraventricular
pressure gradient was thought to be the major
cause of apical aneurysm formation.
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